SDF-1α/CXCL12 enhances GABA and glutamate synaptic activity at serotonin neurons in the rat dorsal raphe nucleus

Neuropharmacology

Volumn 58, Issue 2, 2010, Pages 501-514

  Heinisch, Silke ^a   Kirby, Lynn G ^a  

^a TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

5 HT; Chemokine; Dorsal raphe nucleus; Electrophysiology; GABA; Glutamate; Immunohistochemistry

Indexed keywords

4 AMINOBUTYRIC ACID; CHEMOKINE RECEPTOR CXCR4; GLUTAMIC ACID; STROMAL CELL DERIVED FACTOR 1ALPHA; CENTRAL NERVOUS SYSTEM AGENTS; CXCR4 PROTEIN, RAT; HETEROCYCLIC COMPOUND; PLERIXAFOR; SEROTONIN; STROMAL CELL DERIVED FACTOR 1;

4 AMINOBUTYRIC ACID RELEASE; AMPLITUDE MODULATION; ANIMAL TISSUE; ARTICLE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CYTOPLASM; DORSAL RAPHE NUCLEUS; EXCITATORY POSTSYNAPTIC POTENTIAL; GABAERGIC SYSTEM; INHIBITORY POSTSYNAPTIC POTENTIAL; MALE; NERVE CELL MEMBRANE; NERVE CELL MEMBRANE STEADY POTENTIAL; NONHUMAN; PRIORITY JOURNAL; PROTEIN LOCALIZATION; RAT; SEROTONINERGIC NERVE CELL; SEROTONINERGIC TRANSMISSION; SYNAPSE; ANIMAL; CELL MEMBRANE POTENTIAL; DRUG ANTAGONISM; DRUG EFFECT; EVOKED RESPONSE; IN VITRO STUDY; METABOLISM; NERVE CELL; PHYSIOLOGY; RAPHE NUCLEUS; SPRAGUE DAWLEY RAT; SYNAPTIC TRANSMISSION; SYNAPTOSOME;

ANIMALS; CENTRAL NERVOUS SYSTEM AGENTS; CHEMOKINE CXCL12; EVOKED POTENTIALS; EXCITATORY POSTSYNAPTIC POTENTIALS; GAMMA-AMINOBUTYRIC ACID; GLUTAMIC ACID; HETEROCYCLIC COMPOUNDS; INHIBITORY POSTSYNAPTIC POTENTIALS; MALE; MEMBRANE POTENTIALS; NEURONS; PRESYNAPTIC TERMINALS; RAPHE NUCLEI; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, CXCR4; SEROTONIN; SYNAPSES; SYNAPTIC TRANSMISSION;

EID: 72049117891     PISSN: 00283908     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuropharm.2009.08.022     Document Type: Article

References (77)

1. Abrams J.K., Johnson P.L., Hollis J.H., and Lowry C.A. Anatomic and functional topography of the dorsal raphe nucleus. Ann. N. Y. Acad. Sci. 1018 (2004) 46-57
2. Adler M.W., Geller E.B., Chen X., and Rogers T.J. Viewing chemokines as a third major system of communication in the brain. AAPS J. 7 (2005) E865-E870
3. Adler M.W., and Rogers T.J. Are chemokines the third major system in the brain?. J. Leukoc. Biol. 78 (2005) 1204-1209
4. Bajetto A., Bonavia R., Barbero S., Piccioli P., Costa A., Florio T., and Schettini G. Glial and neuronal cells express functional chemokine receptor CXCR4 and its natural ligand stromal cell-derived factor 1. J. Neurochem. 73 (1999) 2348-2357
5. Bajetto A., Bonavia R., Barbero S., Florio T., and Schettini G. Chemokines and their receptors in the central nervous system. Front. Neuroendocrinol. 22 (2001) 147-184
6. Balabanian K., Lagane B., Infantino S., Chow K.Y., Harriague J., Moepps B., renzana-Seisdedos F., Thelen M., and Bachelerie F. The chemokine SDF-1/CXCL12 binds to and signals through the orphan receptor RDC1 in T lymphocytes. J. Biol. Chem. 280 (2005) 35760-35766
7. Banisadr G., Dicou E., Berbar T., Rostene W., Lombet A., and Haour F. Characterization and visualization of [125I] stromal cell-derived factor-1alpha binding to CXCR4 receptors in rat brain and human neuroblastoma cells. J. Neuroimmunol. 110 (2000) 151-160
8. Banisadr G., Fontanges P., Haour F., Kitabgi P., Rostene W., and Melik P.S. Neuroanatomical distribution of CXCR4 in adult rat brain and its localization in cholinergic and dopaminergic neurons. Eur. J. Neurosci. 16 (2002) 1661-1671
9. Banisadr G., Skrzydelski D., Kitabgi P., Rostene W., and Parsadaniantz S.M. Highly regionalized distribution of stromal cell-derived factor-1/CXCL12 in adult rat brain: constitutive expression in cholinergic, dopaminergic and vasopressinergic neurons. Eur. J. Neurosci. 18 (2003) 1593-1606
10. Baraban J.M., and Aghajanian G.K. Suppression of firing activity of 5-HT neurons in the dorsal raphe by alpha-adrenoceptor antagonists. Neuropharmacology 19 (1980) 355-363
11. Baudouin S.J., Pujol F., Nicot A., Kitabgi P., and Boudin H. Dendrite-selective redistribution of the chemokine receptor CXCR4 following agonist stimulation. Mol. Cell Neurosci. 33 (2006) 160-169
12. Beck S.G., Pan Y.Z., Akanwa A.C., and Kirby L.G. Median and dorsal raphe neurons are not electrophysiologically identical. J. Neurophysiol. 91 (2004) 994-1005
13. Belin M.F., Nanopoulos D., Didier M., Aguera M., Steinbusch H., Verhofstad A., Maitre M., and Pujol J.F. Immunohistochemical evidence for the presence of gamma-aminobutyric acid and serotonin in one nerve cell. A study on the raphe nuclei of the rat using antibodies to glutamate decarboxylase and serotonin. Brain Res. 275 (1983) 329-339
14. Burns J.M., Summers B.C., Wang Y., Melikian A., Berahovich R., Miao Z., Penfold M.E., Sunshine M.J., Littman D.R., Kuo C.J., Wei K., McMaster B.E., Wright K., Howard M.C., and Schall T.J. A novel chemokine receptor for SDF-1 and I-TAC involved in cell survival, cell adhesion, and tumor development. J. Exp. Med. 203 (2006) 2201-2213
15. Callewaere C., Banisadr G., Desarmenien M.G., Mechighel P., Kitabgi P., Rostene W.H., and Melik P.S. The chemokine SDF-1/CXCL12 modulates the firing pattern of vasopressin neurons and counteracts induced vasopressin release through CXCR4. Proc. Natl. Acad. Sci. U.S.A. 103 (2006) 8221-8226
16. Callewaere C., Banisadr G., Rostene W., and Parsadaniantz S.M. Chemokines and chemokine receptors in the brain: implication in neuroendocrine regulation. J. Mol. Endocrinol. 38 (2007) 355-363
17. Callewaere C., Fernette B., Raison D., Mechighel P., Burlet A., Calas A., Kitabgi P., Parsadaniantz S.M., and Rostene W. Cellular and subcellular evidence for neuronal interaction between the chemokine stromal cell-derived factor-1/CXCL 12 and vasopressin: regulation in the hypothalamo-neurohypophysial system of the Brattleboro rats. Endocrinology 149 (2008) 310-319
18. Charney D.S. Monoamine dysfunction and the pathophysiology and treatment of depression. J. Clin. Psychiatry 59 Suppl. 14 (1998) 11-14
19. Clements J.R., Toth D.D., Highfield D.A., and Grant S.J. Glutamate-like immunoreactivity is present within cholinergic neurons of the laterodorsal tegmental and pedunculopontine nuclei. Adv. Exp. Med. Biol. 295 (1991) 127-142
20. Commons K.G. Locally collateralizing glutamate neurons in the dorsal raphe nucleus responsive to substance P contain vesicular glutamate transporter 3 (VGLUT3). J. Chem. Neuroanat (2009)
21. Dantzer R., and Kelley K.W. Twenty years of research on cytokine-induced sickness behavior. Brain Behav. Immun. 21 (2007) 153-160
22. De Paepe B., Schroder J.M., Martin J.J., Racz G.Z., and De Bleecker J.L. Localization of the alpha-chemokine SDF-1 and its receptor CXCR4 in idiopathic inflammatory myopathies. Neuromuscul. Disord. 14 (2004) 265-273
23. Dickens C., Jackson J., Tomenson B., Hay E., and Creed F. Association of depression and rheumatoid arthritis. Psychosomatics 44 (2003) 209-215
24. Dobrunz L.E., and Stevens C.F. Heterogeneity of release probability, facilitation, and depletion at central synapses. Neuron 18 (1997) 995-1008
25. Evans D.L., Charney D.S., Lewis L., Golden R.N., Gorman J.M., Krishnan K.R., Nemeroff C.B., Bremner J.D., Carney R.M., Coyne J.C., Delong M.R., Frasure-Smith N., Glassman A.H., Gold P.W., Grant I., Gwyther L., Ironson G., Johnson R.L., Kanner A.M., Katon W.J., Kaufmann P.G., Keefe F.J., Ketter T., Laughren T.P., Leserman J., Lyketsos C.G., McDonald W.M., McEwen B.S., Miller A.H., Musselman D., O'Connor C., Petitto J.M., Pollock B.G., Robinson R.G., Roose S.P., Rowland J., Sheline Y., Sheps D.S., Simon G., Spiegel D., Stunkard A., Sunderland T., Tibbits Jr. P., and Valvo W.J. Mood disorders in the medically ill: scientific review and recommendations. Biol. Psychiatry 58 (2005) 175-189
26. Fremeau Jr. R.T., Burman J., Qureshi T., Tran C.H., Proctor J., Johnson J., Zhang H., Sulzer D., Copenhagen D.R., Storm-Mathisen J., Reimer R.J., Chaudhry F.A., and Edwards R.H. The identification of vesicular glutamate transporter 3 suggests novel modes of signaling by glutamate. Proc. Natl. Acad. Sci. U.S.A. 99 (2002) 14488-14493
27. Goda Y., and Stevens C.F. Readily releasable pool size changes associated with long term depression. Proc. Natl. Acad. Sci. U.S.A. 95 (1998) 1283-1288
28. Gras C., Herzog E., Bellenchi G.C., Bernard V., Ravassard P., Pohl M., Gasnier B., Giros B., and El M.S. A third vesicular glutamate transporter expressed by cholinergic and serotoninergic neurons. J. Neurosci. 22 (2002) 5442-5451
29. Guyon A., Banisadr G., Rovere C., Cervantes A., Kitabgi P., Melik-Parsadaniantz S., and Nahon J.L. Complex effects of stromal cell-derived factor-1 alpha on melanin-concentrating hormone neuron excitability. Eur. J. Neurosci. 21 (2005) 701-710
30. Guyon A., Rovere C., Cervantes A., Allaeys I., and Nahon J.L. Stromal cell-derived factor-1alpha directly modulates voltage-dependent currents of the action potential in mammalian neuronal cells. J. Neurochem. 93 (2005) 963-973
31. Guyon A., Skrzydelsi D., Rovere C., Rostene W., Parsadaniantz S.M., and Nahon J.L. Stromal cell-derived factor-1alpha modulation of the excitability of rat substantia nigra dopaminergic neurones: presynaptic mechanisms. J. Neurochem. 96 (2006) 1540-1550
32. Guyon A., and Nahon J.L. Multiple actions of the chemokine stromal cell-derived factor-1alpha on neuronal activity. J. Mol. Endocrinol. 38 (2007) 365-376
33. Hatse S., Princen K., Bridger G., De C.E., and Schols D. Chemokine receptor inhibition by AMD3100 is strictly confined to CXCR4. FEBS Lett. 527 (2002) 255-262
34. Hokfelt T., Broberger C., Xu Z.Q., Sergeyev V., Ubink R., and Diez M. Neuropeptides - an overview. Neuropharmacology 39 (2000) 1337-1356
35. Hu X., Dai S., Wu W.J., Tan W., Zhu X., Mu J., Guo Y., Bolli R., and Rokosh G. Stromal cell derived factor-1 alpha confers protection against myocardial ischemia/reperfusion injury: role of the cardiac stromal cell derived factor-1 alpha CXCR4 axis. Circulation 116 (2007) 654-663
36. Jacobs B.L., and Azmitia E.C. Structure and function of the brain serotonin system. Physiol. Rev. 72 (1992) 165-229
37. de Jong E.K., Dijkstra I.M., Hensens M., Brouwer N., van A.M., Liem R.S., Boddeke H.W., and Biber K. Vesicle-mediated transport and release of CCL21 in endangered neurons: a possible explanation for microglia activation remote from a primary lesion. J. Neurosci. 25 (2005) 7548-7557
38. Kalatskaya I., Berchiche Y.A., Gravel S., Limberg B.J., Rosenbaum J.S., and Heveker N. AMD3100 is a CXCR7 ligand with allosteric agonist properties. Mol. Pharmacol. 75 (2009) 1240-1247
39. Kasiyanov A., Fujii N., Tamamura H., and Xiong H. Modulation of network-driven, GABA-mediated giant depolarizing potentials by SDF-1alpha in the developing hippocampus. Dev. Neurosci. 30 (2008) 285-292
40. Kim Y.K., Na K.S., Shin K.H., Jung H.Y., Choi S.H., and Kim J.B. Cytokine imbalance in the pathophysiology of major depressive disorder. Prog. Neuropsychopharmacol. Biol. Psychiatry 31 (2007) 1044-1053
41. Kirby L.G., and Heinisch S. Fractalkine/CX3CL1 enhances GABA synaptic activity at serotonin neurons in the rat dorsal raphe nucleus. Neurosci., (2009) doi:10.1016/j.neuroscience.2009.08.075
42. Kryczek I., Frydman N., Gaudin F., Krzysiek R., Fanchin R., Emilie D., Chouaib S., Zou W., and Machelon V. The chemokine SDF-1/CXCL12 contributes to T lymphocyte recruitment in human pre-ovulatory follicles and coordinates with lymphocytes to increase granulosa cell survival and embryo quality. Am. J. Reprod. Immunol 54 (2005) 270-283
43. Limatola C., Giovannelli A., Maggi L., Ragozzino D., Castellani L., Ciotti M.T., Vacca F., Mercanti D., Santoni A., and Eusebi F. SDF-1alpha-mediated modulation of synaptic transmission in rat cerebellum. Eur. J. Neurosci. 12 (2000) 2497-2504
44. Lu M., Grove E.A., and Miller R.J. Abnormal development of the hippocampal dentate gyrus in mice lacking the CXCR4 chemokine receptor. Proc. Natl. Acad. Sci. U.S.A. 99 (2002) 7090-7095
45. McCandless E.E., Piccio L., Woerner B.M., Schmidt R.E., Rubin J.B., Cross A.H., and Klein R.S. Pathological expression of CXCL12 at the blood-brain barrier correlates with severity of multiple sclerosis. Am. J. Pathol. 172 (2008) 799-808
46. Meucci O., Fatatis A., Simen A.A., Bushell T.J., Gray P.W., and Miller R.J. Chemokines regulate hippocampal neuronal signaling and gp120 neurotoxicity. Proc. Natl. Acad. Sci. U.S.A. 95 (1998) 14500-14505
47. Miller J.T., Bartley J.H., Wimborne H.J., Walker A.L., Hess D.C., Hill W.D., and Carroll J.E. The neuroblast and angioblast chemotaxic factor SDF-1 (CXCL12) expression is briefly up regulated by reactive astrocytes in brain following neonatal hypoxic-ischemic injury. BMC Neurosci. 6 (2005) 63
48. Murdoch C., and Finn A. Chemokine receptors and their role in inflammation and infectious diseases. Blood 95 (2000) 3032-3043
49. Nanopoulos D., Belin M.F., Maitre M., Vincendon G., and Pujol J.F. Immunocytochemical evidence for the existence of GABAergic neurons in the nucleus raphe dorsalis. Possible existence of neurons containing serotonin and GABA. Brain Res. 232 (1982) 375-389
50. Paxinos G., and Watson C. The Rat Brain in Stereotaxic Coordinates (2005), Academic Press, New York
51. Pujol F., Kitabgi P., and Boudin H. The chemokine SDF-1 differentially regulates axonal elongation and branching in hippocampal neurons. J. Cell Sci. 118 (2005) 1071-1080
52. Ragozzino D., Renzi M., Giovannelli A., and Eusebi F. Stimulation of chemokine CXC receptor 4 induces synaptic depression of evoked parallel fibers inputs onto Purkinje neurons in mouse cerebellum. J. Neuroimmunol. 127 (2002) 30-36
53. Reichenberg A., Yirmiya R., Schuld A., Kraus T., Haack M., Morag A., and Pollmacher T. Cytokine-associated emotional and cognitive disturbances in humans. Arch. Gen. Psychiatry 58 (2001) 445-452
54. Rezaie P., Trillo-Pazos G., Everall I.P., and Male D.K. Expression of beta-chemokines and chemokine receptors in human fetal astrocyte and microglial co-cultures: potential role of chemokines in the developing CNS. Glia 37 (2002) 64-75
55. Rostasy K., Egles C., Chauhan A., Kneissl M., Bahrani P., Yiannoutsos C., Hunter D.D., Nath A., Hedreen J.C., and Navia B.A. SDF-1alpha is expressed in astrocytes and neurons in the AIDS dementia complex: an in vivo and in vitro study. J. Neuropathol. Exp. Neurol. 62 (2003) 617-626
56. Rostene W., Kitabgi P., and Parsadaniantz S.M. Chemokines: a new class of neuromodulator?. Nat. Rev. Neurosci. 8 (2007) 895-903
57. Schiepers O.J., Wichers M.C., and Maes M. Cytokines and major depression. Prog. Neuropsychopharmacol. Biol. Psychiatry 29 (2005) 201-217
58. Schonemeier B., Kolodziej A., Schulz S., Jacobs S., Hoellt V., and Stumm R. Regional and cellular localization of the CXCl12/SDF-1 chemokine receptor CXCR7 in the developing and adult rat brain. J. Comp Neurol. 510 (2008) 207-220
59. Shutoh F., Ina A., Yoshida S., Konno J., and Hisano S. Two distinct subtypes of serotonergic fibers classified by co-expression with vesicular glutamate transporter 3 in rat forebrain. Neurosci. Lett. 432 (2008) 132-136
60. Siegert R.J., and Abernethy D.A. Depression in multiple sclerosis: a review. J. Neurol. Neurosurg. Psychiatry 76 (2005) 469-475
61. Skrzydelski D., Guyon A., Dauge V., Rovere C., Apartis E., Kitabgi P., Nahon J.L., Rostene W., and Parsadaniantz S.M. The chemokine stromal cell-derived factor-1/CXCL12 activates the nigrostriatal dopamine system. J. Neurochem. 102 (2007) 1175-1183
62. Sozzani S., Locati M., Allavena P., Van D.J., and Mantovani A. Chemokines: a superfamily of chemotactic cytokines. Int. J. Clin. Lab. Res. 26 (1996) 69-82
63. Stumm R.K., Rummel J., Junker V., Culmsee C., Pfeiffer M., Krieglstein J., Hollt V., and Schulz S. A dual role for the SDF-1/CXCR4 chemokine receptor system in adult brain: isoform-selective regulation of SDF-1 expression modulates CXCR4-dependent neuronal plasticity and cerebral leukocyte recruitment after focal ischemia. J. Neurosci. 22 (2002) 5865-5878
64. Stumm R., Kolodziej A., Schulz S., Kohtz J.D., and Hollt V. Patterns of SDF-1alpha and SDF-1gamma mRNAs, migration pathways, and phenotypes of CXCR4-expressing neurons in the developing rat telencephalon. J. Comp. Neurol. 502 (2007) 382-399
65. Stumm R., and Hollt V. CXC chemokine receptor 4 regulates neuronal migration and axonal pathfinding in the developing nervous system: implications for neuronal regeneration in the adult brain. J. Mol. Endocrinol. 38 (2007) 377-382
66. Tan Y., Shao H., Eton D., Yang Z., onso-Diaz L., Zhang H., Schulick A., Livingstone A.S., and Yu H. Stromal cell-derived factor-1 enhances pro-angiogenic effect of granulocyte-colony stimulating factor. Cardiovasc. Res. 73 (2007) 823-832
67. Tao R., and Auerbach S.B. Regulation of serotonin release by GABA and excitatory amino acids. J. Psychopharmacol. 14 (2000) 100-113
68. Tao R., and Auerbach S.B. Influence of inhibitory and excitatory inputs on serotonin efflux differs in the dorsal and median raphe nuclei. Brain Res. 961 (2003) 109-120
69. Tran P.B., Banisadr G., Ren D., Chenn A., and Miller R.J. Chemokine receptor expression by neural progenitor cells in neurogenic regions of mouse brain. J. Comp. Neurol. 500 (2007) 1007-1033
70. Tran P.B., and Miller R.J. HIV-1, chemokines and neurogenesis. Neurotox. Res. 8 (2005) 149-158
71. Vandermaelen C.P., and Aghajanian G.K. Electrophysiological and pharmacological characterization of serotonergic dorsal raphe neurons recorded extracellularly and intracellularly in rat brain slices. Brain Res. 289 (1983) 109-119
72. Vertes R.P. A PHA-L analysis of ascending projections of the dorsal raphe nucleus in the rat. J. Comp. Neurol. 313 (1991) 643-668
73. Vertes R.P., Fortin W.J., and Crane A.M. Projections of the median raphe nucleus in the rat. J. Comp. Neurol. 407 (1999) 555-582
74. Watanabe T., Pakala R., Katagiri T., and Benedict C.R. Monocyte chemotactic protein 1 amplifies serotonin-induced vascular smooth muscle cell proliferation. J. Vasc. Res. 38 (2001) 341-349
75. van West D., and Maes M. Activation of the inflammatory response system: a new look at the etiopathogenesis of major depression. Neuro. Endocrinol. Lett. 20 (1999) 11-17
76. Yoshimura M., Higashi H., and Nishi S. Noradrenaline mediates slow excitatory synaptic potentials in rat dorsal raphe neurons in vitro. Neurosci. Lett. 61 (1985) 305-310
77. Zupanc G.K. Peptidergic transmission: from morphological correlates to functional implications. Micron 27 (1996) 35-91